Comments on "Association between Ala-9Val polymorphism of MnSOD gene and schizophrenia" by O. Akyol et al. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 2005, 123-131

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 4, 2006, Pages 762-763

  Pae, Chi Un ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; MANGANESE SUPEROXIDE DISMUTASE; VALINE;

CHINESE; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; EUROPE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; JAPAN; LETTER; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ALANINE; HUMANS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE; VALINE;

EID: 33646093949     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.01.025     Document Type: Letter

References (11)

1. Akyol O., Yanik M., Elyas H., Namli M., Canatan H., Akin H., et al. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 123-131
2. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol 49 (1995) 127-140
3. Harada S., Tachikawa H., and Kawanishi Y. Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Biochem Biophys Res Commun 281 (2001) 267-271
4. Hori H., Ohmori O., Shinkai T., Kojima H., Okano C., Suzuki T., et al. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacology 23 (2000) 170-177
5. Liou Y.J., Wang Y.C., Lin C.C., Bai Y.M., Lai I.C., Liao D.L., et al. Association analysis of NAD(P)Hratioquinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan. Int J Neuropsychopharmacol 8 (2005) 483-486
6. Pae C.U., Yu H.S., Kim J.J., Lee C.U., Lee S.J., Jun T.Y., et al. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. Int J Neuropsychopharmacol 7 (2004) 495-500
7. Pae C.U., Yu H.S., Kim J.J., Kim W., Lee C.U., Lee S.J., et al. Glutathione S-transferase M1 polymorphism may contribute to schizophrenia in the Korean population. Psychiatr Genet 14 (2004) 147-150
8. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., and Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 226 (1996) 561-565
9. Swartz J.R., Burgoyne K., Smith M., Gadasally R., Ananth J., and Ananth K. Tardive dyskinesia and ethnicity: review of the literature. Ann Clin Psychiatry 9 (1997) 53-59
10. Zhang Z., Zhang X., Hou G., Sha W., and Reynolds G.P. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism. J Psychiatr Res 36 (2002) 317-324
11. Zhang Z.J., Zhang X.B., Hou G., Yao H., and Reynolds G.P. Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia. Psychiatr Genet 13 (2003) 187-192